James G Pfaus Selected Research

James G Pfaus Research Topics

Disease

13	Lordosis 11/2023 - 02/2006
3	Pain (Aches) 04/2014 - 07/2007
2	Cognitive Dysfunction 12/2023 - 10/2021
2	Psychological Sexual Dysfunctions (Sexual Arousal Disorder) 01/2022 - 05/2013
1	Autistic Disorder (Autism) 12/2023
1	Autism Spectrum Disorder 12/2023
1	Mental Disorders (Mental Disorder) 12/2023
1	Hyperprolactinemia 11/2023
1	Alzheimer Disease (Alzheimer's Disease) 10/2021
1	Schizophrenia (Dementia Praecox) 10/2021
1	Substance-Related Disorders (Drug Abuse) 12/2010
1	Movement Disorders (Movement Disorder) 12/2010
1	Psychotic Disorders (Schizoaffective Disorder) 12/2010
1	Bipolar Disorder (Manic Depressive Psychosis) 10/2009
1	Cocaine-Related Disorders (Cocaine Addiction) 11/2007
1	Peritonitis 07/2007

Drug/Important Bio-Agent (IBA)

5	Estrogens (Estrogen)FDA Link 01/2022 - 02/2006
4	estradiol 3-benzoate (estradiol benzoate)IBA 11/2023 - 09/2015
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 11/2022 - 01/2020
3	Progesterone FDA LinkGeneric 11/2022 - 01/2020
3	SteroidsIBA 11/2021 - 01/2020
2	ApelinIBA 11/2023 - 01/2022
2	apelin-13 peptideIBA 11/2023 - 01/2022
2	Estradiol (Delestrogen)FDA LinkGeneric 11/2022 - 11/2021
2	tiboloneIBA 11/2021 - 01/2020
2	iturelix (Antide)IBA 11/2021 - 01/2020
2	Glutamic Acid (Glutamate)FDA Link 09/2015 - 02/2006
2	melanotan-IIIBA 04/2014 - 11/2006
2	FG 9041 (DNQX)IBA 07/2012 - 02/2006
2	Dopamine (Intropin)FDA LinkGeneric 12/2010 - 10/2009
1	Valproic Acid (Depakote)FDA LinkGeneric 12/2023
1	Anticonvulsants (Antiepileptic Drugs)IBA 12/2023
1	Cabergoline FDA LinkGeneric 11/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2023
1	Peptides (Polypeptides)IBA 11/2023
1	KT 5823IBA 11/2023
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 11/2023
1	melanin-concentrating hormone (melanin concentrating hormone)IBA 11/2022
1	KisspeptinsIBA 11/2022
1	bremelanotideIBA 01/2022
1	ProstaglandinsIBA 11/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2021
1	4- (4- cyano- 2- (2- (4- fluoronaphthalen- 1- yl)propionylamino)phenyl)butyric acidIBA 11/2021
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 11/2021
1	Dinoprostone (PGE2)FDA Link 11/2021
1	Oxytocin (Pitocin)FDA LinkGeneric 11/2021
1	Prostaglandin Receptors (Prostaglandin Receptor)IBA 11/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 11/2021
1	Mifepristone (RU 486)FDA Link 01/2020
1	Tamoxifen FDA LinkGeneric 01/2020
1	Progestins (Progestagens)IBA 01/2020
1	Flavin-Adenine Dinucleotide (FAD)IBA 01/2019
1	AMPA Receptors (AMPA Receptor)IBA 09/2015
1	ZymosanIBA 04/2014
1	Pregabalin (Lyrica)FDA Link 04/2014
1	Analgesics (Analgesic Drugs)IBA 04/2014
1	Apomorphine FDA Link 04/2014
1	CarrageenanIBA 04/2014
1	Serotonin 5-HT2 Receptor AntagonistsIBA 05/2013
1	flibanserin (BIMT 17)IBA 05/2013
1	Serotonin 5-HT1 Receptor AgonistsIBA 05/2013
1	salicylhydroxamic acid (SHAM)IBA 07/2012
1	Serotonin (5 Hydroxytryptamine)IBA 10/2009
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 10/2009
1	Paroxetine (Paxil)FDA LinkGeneric 10/2009
1	Opioid Analgesics (Opioids)IBA 11/2007
1	Cocaine (Cocaine HCl)IBA 11/2007
1	Methadone (Dolophine)FDA LinkGeneric 11/2007
1	alpha-MSHIBA 11/2006
1	Cyclic PeptidesIBA 11/2006
1	Hormones (Hormone)IBA 02/2006
1	Kainic Acid (Kainate)IBA 02/2006
1	N-Methylaspartate (NMDA)IBA 02/2006
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 02/2006
1	6-Cyano-7-nitroquinoxaline-2,3-dione (6 Cyano 7 nitroquinoxaline 2,3 dione)IBA 02/2006

Therapy/Procedure

2	Injections 11/2023 - 11/2021
1	Therapeutics 12/2023
1	Punctures 07/2007